DCTH — DELCATH SYSTEMS, INC.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 872912 ·
Last close
$16.75
Market Cap
$581.20M
52W High
$17.42
52W Low
$10.20
ADV30
606,415
Next earnings
2026-11-03
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 29,133,000 | 26,148,000 | 2,395,000 | 2,668,000 | 137,018,000 | 47,521,000 | 15,873,000 |
| Mar 2026 | 24,994,000 | 21,258,000 | -1,637,000 | -1,070,000 | 124,838,000 | 41,313,000 | 12,128,000 |
| Dec 2025 | 20,728,000 | 17,718,000 | -2,184,000 | -1,896,000 | 123,632,000 | 43,454,000 | 12,413,000 |
| Sep 2025 | 20,563,000 | 17,939,000 | -388,000 | 830,000 | 124,295,000 | 41,813,000 | 9,448,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$21,170,000
Investing CF
$-2,013,000
Financing CF
$9,414,000
CapEx
$-1,977,000
Dividends Paid
—
Buybacks
$-3,000,000
EPS Diluted TTM
$0.01
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$-527,250,000
Inventory
$11,713,000
Receivables
$16,923,000
ST Investments
$48,381,000
EBIT TTM
$-1,814,000
Pretax Income TTM
$1,292,000
Interest Exp TTM
—
Analysts
5
Yahoo Snapshot (yfinance, live)
Total Revenue
$95,418,000
EBITDA
$-1,455,000
Free Cash Flow
$18,117,250
Enterprise Value
$487,765,824
Total Cash
$95,902,000
Total Debt
$2,463,000
Shares Out
34,698,795
Trailing EPS
$0.01
Book Value
$3.50
ROE
0.5%
ROA
-0.9%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 85,231,000 | 660,000 | 2,700,000 | 123,632,000 | 12,413,000 | — | 22,516,000 |
| Dec 2024 | 37,205,000 | -12,410,000 | -26,386,000 | 76,589,000 | 7,843,000 | — | -18,681,000 |
| Dec 2023 | 2,065,000 | -38,182,000 | -47,678,000 | 38,613,000 | 22,836,000 | — | -31,251,000 |
| Dec 2022 | 2,719,000 | -33,853,000 | -36,508,000 | 17,862,000 | 23,721,000 | — | -24,950,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$0.04
Max Pain — expiry 2026-11-20
max pain strike: $10.00 · spot: $16.75 · call oi: 990 · put oi: 159
Expected Move to 2026-11-20:
±$8.35
(49.85%) —
implied range
$8.40 –
$25.10
· ATM straddle on $17.50 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| BWAY | Brainsway Ltd. | $570.28M | $14.19 | — |
| BRSYF | Brainsway Ltd. | $608.06M | $15.13 | — |
| MDXG | MIMEDX GROUP, INC. | $622.40M | $4.27 | — |
| CERS | CERUS CORP | $542.10M | $2.69 | — |
| TCMD | TACTILE SYSTEMS TECHNOLOGY INC | $529.16M | $23.36 | — |
News headlines (Yahoo Finance, 1h cache)
Here's Why Delcath Systems, Inc. (DCTH) is a Great Momentum Stock to Buy
2026-08-11 16:00 · Yahoo
These Two Stocks Hit Fresh 52-Week Highs Today – DCTH Clocks Best Day In Nearly 15 Months
2026-08-06 17:49 · Yahoo
Delcath Systems Q2 Earnings Call Highlights
2026-08-06 16:04 · Yahoo
Delcath Systems, Inc. (DCTH) Tops Q2 Earnings and Revenue Estimates
2026-08-06 13:50 · Yahoo
Delcath Systems Reports Second Quarter 2026 Results and Business Highlights
2026-08-06 12:01 · Yahoo
Delcath Systems to Host Second Quarter 2026 Earnings Call
2026-07-23 20:01 · Yahoo
Delcath Systems, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2026-07-16 20:01 · Yahoo
Delcath Systems Announces First Patient Dosed in Phase 2 Clinical Trial of HEPZATO™ in Liver-Dominant Metastatic Breast Cancer
2026-07-09 12:00 · Yahoo
Delcath (DCTH) Q1 2026 Earnings Transcript
2026-05-08 16:25 · Yahoo
Delcath Systems (DCTH) Is a Great Choice for 'Trend' Investors, Here's Why
2026-08-12 12:55 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.